meta_pixel
Tapesearch Logo
Log in
The John Batchelor Show

THE HASTE WAS THE KNOWN RISK: 5/8 A Shot to Save the World: The Inside Story of the Life-or-Death Race for a COVID-19 Vaccine, by Gregory Zuckerman Kindle Edition

The John Batchelor Show

John Batchelor

Society & Culture, Arts, News, Books

4.52.8K Ratings

🗓️ 6 October 2024

⏱️ 9 minutes

🧾️ Download transcript

Summary

THE HASTE WAS THE KNOWN RISK: 5/8   A Shot to Save the World: The Inside Story of the Life-or-Death Race for a COVID-19 Vaccine, by  Gregory Zuckerman   Kindle Edition

https://www.amazon.com/Shot-Save-World-Life-Death/dp/059342039X/ref=tmm_hrd_swatch_0?_encoding=UTF8&qid=&sr=

Few were ready when a mysterious respiratory illness emerged in Wuhan, China in January 2020. Politicians, government officials, business leaders, and public-health professionals were unprepared for the most devastating pandemic in a century. Many of the world’s biggest drug and vaccine makers were slow to react or couldn’t muster an effective response.

It was up to a small group of unlikely and untested scientists and executives to save civilization. A French businessman dismissed by many as a fabulist. A Turkish immigrant with little virus experience. A quirky Midwesterner obsessed with insect cells. A Boston scientist employing questionable techniques. A British scientist despised by his peers. Far from the limelight, each had spent years developing innovative vaccine approaches. Their work was met with skepticism and scorn. By 2020, these individuals had little proof of progress. Yet they and their colleagues wanted to be the ones to stop the virus holding the world hostage. They scrambled to turn their life’s work into life-saving vaccines in a matter of months, each gunning to make the big breakthrough—and to beat each other for the glory that a vaccine guaranteed.

1919 QUEENSLAND AUSTRALIA QUARENTINE CAMP

Transcript

Click on a timestamp to play from that location

0:00.0

This is a

0:05.0

This is CBS Eye on the World.

0:08.0

Here's John Bachelor.

0:10.0

Gregory Zuckerman, a shot to save the world, is his new book, The Inside Story of the

0:16.0

life or death race for a COVID-19 vaccine.

0:19.2

The story so far.

0:21.0

The world is slowly registering that something terrible has happened.

0:27.0

They don't know where, they don't know when, but they know it's coming.

0:31.0

What is to be done? We know it now is COVID-19.

0:35.0

All that identification was slowly over the weeks in late December 19, early January, early February 20. The pursuers of the solution are not one

0:49.5

group. They're not talking to each other. They're in direct competition in the marketplace.

0:55.1

Moderna, a small company relative to the drug giants.

0:59.5

J&J gets involved, a giant company, a bio and tech, a little company in Germany is attached

1:07.7

now to Pfizer, a great American company, and Novavax along with Oxford University, the Jenner Institute that

1:18.6

teams up with AstraZeneca. You need two parts here. You need the research and the manufacturing. You got to get them all organized and that is

1:27.8

impossible to do in less than a year and a half, less than five years. making vaccines is extremely arduous very expensive and

1:35.9

you can miss so what happens to get them all moving in the same direction competition

1:41.8

the marketplace and cash

1:44.3

Gregory we begin with March 2nd at the White House always love scenes

1:49.6

giant opera scenes that you introduce in your books, Gregory.

1:53.6

The gathering is initially meant to bring in the executives

1:58.6

and the president of the United States, Donald Trump,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from John Batchelor, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of John Batchelor and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.